Whole Body MRI imaging in bone metastases

• Research type

  Research Study

• Full title

  Imaging sub-study utilizing whole body magnetic resonance imaging to evaluate metastatic bone disease response within the Phase 3 studies (COMET -1/-2) of cabozantinib (XL184) in patients with metastatic prostate cancer

• IRAS ID

  121892

• Contact name

  Dow-Mu Koh

• Contact email

  dow-mu.koh@rmh.nhs.uk

• Sponsor organisation

  The Royal Marsden NHS Foundation Trust

• REC name

  London - Chelsea Research Ethics Committee

• REC reference

  13/LO/0260

• Date of REC Opinion

  9 Apr 2013

• REC opinion

  Further Information Favourable Opinion